Picture of SymBio Pharmaceuticals logo

4582 — SymBio Pharmaceuticals News Story

0.000.00%
jp flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Table: SymBio Pharmaceuticals - 9-MTH parent results

Nov 9 (Reuters)- 
             SymBio Pharmaceuticals Limited 
             PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 9 months ended      9 months ended        Year to  
                Sep 30, 2018        Sep 30, 2017      Dec 31, 2018  
                   LATEST             YEAR-AGO           LATEST     
                   RESULTS             RESULTS          FORECAST    
  Sales             3.03                2.42              4.20      
                 (+25.5 pct)         (+71.7 pct)       (+22.0 pct)  
  Operating       loss 1.91           loss 3.51         loss 2.98   
  Recurring       loss 1.94           loss 3.55         loss 3.04   
  Net             loss 1.94           loss 3.55         loss 3.06   
  EPS          loss 31.31 yen      loss 72.64 yen    loss 46.53 yen 
  Ann Div                                NIL               NIL      
  -Q2 div            NIL                 NIL                        
  -Q4 div                                NIL               NIL      
  
  NOTE - SymBio Pharmaceuticals Limited. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4582.T

Recent news on SymBio Pharmaceuticals

See all news